MoneyWorks4Me

Arian Investment hikes stake in Bliss GVS Pharma

28 Dec 2018 Evaluate

Arian Investment has increased its holdings in Bliss GVS Pharma and now aggregating to more than five percent of the shares of the company Bliss GVS. Arian Investment’s holding in the company now stands at 9.22%.

Bliss GVS Pharma is a fast-growing Pharmaceutical Company with a proven track record of developing, manufacturing and marketing high quality pharmaceutical formulations at affordable prices for the global market.

Peers
Company Name CMP
Sun Pharma. Inds. 1860.10
Dr. Reddys Labs. 1153.15
Cipla 1357.05
Lupin 2056.55
Zydus Lifesciences 1109.90
View more..